Hyderabad-based Dr Reddy's Laboratories (DRL ... time adjustments related to the acquisition of the Nicotine Replacement ...

By Rishika Sadam and Kashish Tandon HYDERABAD/BENGALURU (Reuters) -Indian generic drugmaker Dr Reddy's Laboratories' second-quarter profit was hit by one-time charges related to its joint venture with ...

Ladies and gentlemen, good day, and welcome to the Quarter Two FY 2025 Earnings Conference Call of Dr. Reddy's Laboratories Limited. As a reminder, all participants' lines will be in the listen-only ...

Dr Reddy's Laboratories on Monday said its Switzerland-based subsidiary has completed the acquisition of Haleon plc's global ...

The U.S. unit of Indian drugmaker Dr. Reddy’s Laboratories is recalling 331,590 bottles of cinacalcet tablets used to treat hyperparathyroidism due to the presence of a known carcinogen. | The U.S.

According to the latest Enforcement Report by the US Food and Drug Administration, Dr Reddy's is recalling the 3,31,590 ...

I was alarmed by a recent Star guest commentary that leveled a number of false attacks against Dr. Prasanth Reddy. The ...

Haleon To Offload Non-Core Nicotine Therapy Business To Dr. Reddy's For Over $600M Haleon has agreed to sell its nicotine replacement therapy business outside the U.S. to Dr. Reddy's Laboratories ...

Dr. Reddy's Q2 net income dropped to $160 million from $177M YoY, with revenue up 16.6% to $957 million. Global generics revenue grew 17% YoY, driven by sales volume gains and new launches. Dr.

Indian generic drugmaker Dr Reddy's Laboratories reported a second-quarter profit that missed analysts' expectations on Tuesday, weighed down by pricing pressure in a competitive North American market ...